Cargando…

Intravenous Application of a Primary Sevoflurane Metabolite Improves Outcome in Murine Septic Peritonitis: First Results

Volatile anesthetics are known to have immunomodulatory effects in conditions of organ injury. A recent study in an experimental sepsis model has shown remarkably improved survival when mice were exposed to volatile anesthetics. In the present study, we show that hexafluoroisopropanol – a water-solu...

Descripción completa

Detalles Bibliográficos
Autores principales: Herrmann, Inge K., Castellon, Maricela, Schwartz, David E., Hasler, Melanie, Urner, Martin, Hu, Guochang, Minshall, Richard D., Beck-Schimmer, Beatrice
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747167/
https://www.ncbi.nlm.nih.gov/pubmed/23977207
http://dx.doi.org/10.1371/journal.pone.0072057
_version_ 1782280879008120832
author Herrmann, Inge K.
Castellon, Maricela
Schwartz, David E.
Hasler, Melanie
Urner, Martin
Hu, Guochang
Minshall, Richard D.
Beck-Schimmer, Beatrice
author_facet Herrmann, Inge K.
Castellon, Maricela
Schwartz, David E.
Hasler, Melanie
Urner, Martin
Hu, Guochang
Minshall, Richard D.
Beck-Schimmer, Beatrice
author_sort Herrmann, Inge K.
collection PubMed
description Volatile anesthetics are known to have immunomodulatory effects in conditions of organ injury. A recent study in an experimental sepsis model has shown remarkably improved survival when mice were exposed to volatile anesthetics. In the present study, we show that hexafluoroisopropanol – a water-soluble primary sevoflurane metabolite – has beneficial effects on the overall survival in a murine model of cecal ligation and puncture. Seven-day survival as well as tissue damage markers including transaminases and high mobility group box protein-1 were assessed as measures of end organ damage. In animals undergoing cecal ligation and puncture procedure hexafluoroisopropanol conditioning - but not late postconditioning 24 hours after sepsis induction - significantly increased survival rate (17% vs. 77%, p = 0.037) and attenuated secretion of organ damage markers. This study shows survival benefits by administration of the metabolite of a volatile anesthetic. If successfully translated, hexafluoroisopropanol might offer interesting therapeutic opportunities in the future treatment of abdominal sepsis.
format Online
Article
Text
id pubmed-3747167
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-37471672013-08-23 Intravenous Application of a Primary Sevoflurane Metabolite Improves Outcome in Murine Septic Peritonitis: First Results Herrmann, Inge K. Castellon, Maricela Schwartz, David E. Hasler, Melanie Urner, Martin Hu, Guochang Minshall, Richard D. Beck-Schimmer, Beatrice PLoS One Research Article Volatile anesthetics are known to have immunomodulatory effects in conditions of organ injury. A recent study in an experimental sepsis model has shown remarkably improved survival when mice were exposed to volatile anesthetics. In the present study, we show that hexafluoroisopropanol – a water-soluble primary sevoflurane metabolite – has beneficial effects on the overall survival in a murine model of cecal ligation and puncture. Seven-day survival as well as tissue damage markers including transaminases and high mobility group box protein-1 were assessed as measures of end organ damage. In animals undergoing cecal ligation and puncture procedure hexafluoroisopropanol conditioning - but not late postconditioning 24 hours after sepsis induction - significantly increased survival rate (17% vs. 77%, p = 0.037) and attenuated secretion of organ damage markers. This study shows survival benefits by administration of the metabolite of a volatile anesthetic. If successfully translated, hexafluoroisopropanol might offer interesting therapeutic opportunities in the future treatment of abdominal sepsis. Public Library of Science 2013-08-19 /pmc/articles/PMC3747167/ /pubmed/23977207 http://dx.doi.org/10.1371/journal.pone.0072057 Text en © 2013 Herrmann et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Herrmann, Inge K.
Castellon, Maricela
Schwartz, David E.
Hasler, Melanie
Urner, Martin
Hu, Guochang
Minshall, Richard D.
Beck-Schimmer, Beatrice
Intravenous Application of a Primary Sevoflurane Metabolite Improves Outcome in Murine Septic Peritonitis: First Results
title Intravenous Application of a Primary Sevoflurane Metabolite Improves Outcome in Murine Septic Peritonitis: First Results
title_full Intravenous Application of a Primary Sevoflurane Metabolite Improves Outcome in Murine Septic Peritonitis: First Results
title_fullStr Intravenous Application of a Primary Sevoflurane Metabolite Improves Outcome in Murine Septic Peritonitis: First Results
title_full_unstemmed Intravenous Application of a Primary Sevoflurane Metabolite Improves Outcome in Murine Septic Peritonitis: First Results
title_short Intravenous Application of a Primary Sevoflurane Metabolite Improves Outcome in Murine Septic Peritonitis: First Results
title_sort intravenous application of a primary sevoflurane metabolite improves outcome in murine septic peritonitis: first results
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747167/
https://www.ncbi.nlm.nih.gov/pubmed/23977207
http://dx.doi.org/10.1371/journal.pone.0072057
work_keys_str_mv AT herrmanningek intravenousapplicationofaprimarysevofluranemetaboliteimprovesoutcomeinmurinesepticperitonitisfirstresults
AT castellonmaricela intravenousapplicationofaprimarysevofluranemetaboliteimprovesoutcomeinmurinesepticperitonitisfirstresults
AT schwartzdavide intravenousapplicationofaprimarysevofluranemetaboliteimprovesoutcomeinmurinesepticperitonitisfirstresults
AT haslermelanie intravenousapplicationofaprimarysevofluranemetaboliteimprovesoutcomeinmurinesepticperitonitisfirstresults
AT urnermartin intravenousapplicationofaprimarysevofluranemetaboliteimprovesoutcomeinmurinesepticperitonitisfirstresults
AT huguochang intravenousapplicationofaprimarysevofluranemetaboliteimprovesoutcomeinmurinesepticperitonitisfirstresults
AT minshallrichardd intravenousapplicationofaprimarysevofluranemetaboliteimprovesoutcomeinmurinesepticperitonitisfirstresults
AT beckschimmerbeatrice intravenousapplicationofaprimarysevofluranemetaboliteimprovesoutcomeinmurinesepticperitonitisfirstresults